Feature Channels: Alzheimer's and Dementia

Filters close
Newswise: UCLA selected by Centers for Medicare & Medicaid Services to test Medicare dementia care model
Released: 19-Jul-2024 5:05 PM EDT
UCLA selected by Centers for Medicare & Medicaid Services to test Medicare dementia care model
University of California, Los Angeles (UCLA), Health Sciences

UCLA has been selected by the Centers for Medicare & Medicaid Services (CMS) to participate in a new Medicare alternative payment model designed to support people living with dementia and their caregivers.

Newswise: 1920_gettyimages-1486145188.jpg?10000
Released: 19-Jul-2024 1:05 PM EDT
Cedars-Sinai Programs Earn Distinction for Prioritizing Older Adults’ Needs
Cedars-Sinai

Cedars-Sinai programs serving older patients and people with dementia have earned esteemed national distinctions reserved for healthcare models that prioritize improved health and wellness among older adults—a rapidly growing segment of the U.S. population expected to nearly double in the coming decades.

access_time Embargo lifts in 2 days
This news release is embargoed until 24-Jul-2024 4:00 PM EDT Released to reporters: 19-Jul-2024 12:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 24-Jul-2024 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 19-Jul-2024 10:05 AM EDT
Wash U researchers shine light on amyloid architecture
Washington University in St. Louis

Researchers at Washington University in St. Louis use microscopy to chart amyloid beta’s underlying structure and yield insight into neurodegenerative disease

Newswise:Video Embedded curious-by-nature-why-is-metabolomics-important-to-alzheimer-s-dr-steward-graham
VIDEO
Released: 19-Jul-2024 8:05 AM EDT
Curious by Nature: Why is Metabolomics Important to Alzheimer’s? - Dr. Steward Graham
Newswise

In this episode, Dr. Stewart Graham discusses metabolomics in Alzheimer’s disease. He investigates how the disease affects the brain’s metabolism of small molecules such as lipids and amino acids.

Newswise: Mayo Clinic scientists define new type of memory loss in older adults
Released: 16-Jul-2024 8:00 PM EDT
Mayo Clinic scientists define new type of memory loss in older adults
Mayo Clinic

Researchers at Mayo Clinic have established new criteria for a memory-loss syndrome in older adults that specifically impacts the brain's limbic system. It can often be mistaken for Alzheimer's disease.

Released: 15-Jul-2024 8:05 PM EDT
Participate in Study to Reduce Disparate Growth of Alzheimer’s Disease in Black Population
Corewell Health

Corewell Health is working with Johns Hopkins Bloomberg School of Public Health and North Carolina Agricultural and Technical State University to learn more about the multi-level risk and biopsychosocial factors that contribute to Alzheimer’s disease in Black Americans, leading to the development of effective, tailored behavioral and pharmacological interventions aimed at reducing the condition’s disparate attack.

Newswise: Racial disparities in dementia determined by social factors
Released: 11-Jul-2024 4:05 PM EDT
Racial disparities in dementia determined by social factors
Washington University in St. Louis

A study conducted in four Latin American countries by researchers at Washington University School of Medicine in St. Louis reveals that racial disparities in brain health are due to social factors, with genetic ancestry playing no role.

Released: 10-Jul-2024 4:05 PM EDT
UC Irvine nursing professor is inducted into Sigma Theta Tau international hall of fame
University of California, Irvine

Jung-Ah Lee, professor and associate dean for diversity, equity, inclusion and belonging at the University of California, Irvine’s Sue & Bill Gross School of Nursing, has been inducted into the International Nurse Researcher Hall of Fame by the Sigma Theta Tau International Honor Society of Nursing.

8-Jul-2024 1:00 PM EDT
Can We Predict How Fast Cognitive Decline Will Occur with Early Alzheimer’s?
American Academy of Neurology (AAN)

A new study looks at predicting how quickly people with early Alzheimer’s disease will experience cognitive decline. The study is published in the July 10, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. It also looked at how the new drugs recently approved for the disease may reduce decline.

Released: 10-Jul-2024 10:05 AM EDT
Mount Sinai Health System Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model
Mount Sinai Health System

The Mount Sinai Health System announced it had been selected by the Centers for Medicare & Medicaid Services (CMS) to participate in a new Medicare alternative payment model designed to support people living with dementia and their caregivers.

Released: 9-Jul-2024 10:05 AM EDT
Advocate Health champions health equity through new, innovative dementia care model
Wake Forest University School of Medicine

Advocate Health has been selected by the Centers for Medicare and Medicaid Services (CMS) to participate in the Guiding an Improved Dementia Experience (GUIDE) Model. Following years of neurocognitive disorders research pioneered by Advocate Health's academic core, Wake Forest University School of Medicine, patients across the health system’s footprint will now benefit from the GUIDE Model’s new standardized approach to care for patients with dementia and their caregivers.

27-Jun-2024 11:05 AM EDT
Can Inflammation in Early Adulthood Affect Memory, Thinking in Middle Age?
American Academy of Neurology (AAN)

Having higher levels of inflammation in your 20s and 30s may be linked to having memory and thinking problems at middle age, according to a study published in the July 3, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study looked at levels of C-reactive protein (CRP) in the blood.

Released: 28-Jun-2024 12:05 PM EDT
Penn researchers will investigate link between TBI and dementia with $10M NIH grant
Perelman School of Medicine at the University of Pennsylvania

An international team of researchers led by Penn Medicine will investigate the link between traumatic brain injuries (TBI) and Alzheimer’s disease and related dementias (ADRD) over the next five years with a $10 million grant from the National Institute of Neurological Disorders and Stroke (NINDS).

Released: 27-Jun-2024 7:05 AM EDT
Alzheimer's Association Workshop Publishes Biology Based Criteria For Diagnosis And Staging Of Alzheimer's Disease
Alzheimer's Association

A workgroup convened by the Alzheimer's Association has published revised criteria for the diagnosis and staging of Alzheimer's disease that are based on the biology of the disease and reflect recent advancements in Alzheimer's research, diagnostics and treatment. The 2024 update includes an updated biomarker classification system that includes blood-based biomarkers (BBM) and a revised disease staging system.

12-Jun-2024 9:05 PM EDT
New research identifies biomarkers that link alcohol use disorder and Alzheimer disease
Research Society on Alcoholism

Researchers agree that alcohol use can produce global and regional tissue volume changes in the brain, and that excessive alcohol use is associated with dementia and cognitive decline. A new study has examined the relationship between Alzheimer disease – the most common type of dementia – and alcohol use disorder (AUD), discovering biomarkers that link the two.

     
Released: 26-Jun-2024 6:00 AM EDT
Pesquisadores identificam alterações vasculares no cérebro ligadas à doença de Alzheimer
Mayo Clinic

A barreira hematoencefálica — uma rede de vasos sanguíneos e tecidos que nutre e protege o cérebro de substâncias nocivas que circulam no sangue — é interrompida na doença de Alzheimer. No momento, pesquisadores e colaboradores da Mayo Clinic descobriram assinaturas moleculares únicas de disfunção da barreira hematoencefálica que poderiam apontar para novas formas de se diagnosticar e tratar a doença. Os resultados dessa descoberta estão publicados na Nature Communications.



close
2.48171